Insider Monkey5h agobullish
Eli Lilly (LLY) Reports Q1 2026 Revenue Surge of 56% Following FDA Approval of FoundayoEli Lilly and Company (NYSE:LLY) is one of the best growth stocks to invest in for the next 2 years. On April 30, Eli Lilly delivered a powerful performance for Q1 2026, with revenue surging 56% to $19.8 billion. This growth was fueled by a 65% increase in volume, led by the strong demand for […]
